Cargando…
Development and Application of Performance Assessment Criteria for Next-Generation Sequencing-Based HIV Drug Resistance Assays
Next-generation sequencing (NGS)-based HIV drug resistance (HIVDR) assays outperform conventional Sanger sequencing in scalability, sensitivity, and quantitative detection of minority resistance variants. Thus far, HIVDR assays have been applied primarily in research but rarely in clinical settings....
Autores principales: | Becker, Michael G., Liang, Dun, Cooper, Breanna, Le, Yan, Taylor, Tracy, Lee, Emma R., Wu, Sutan, Sandstrom, Paul, Ji, Hezhao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354553/ https://www.ncbi.nlm.nih.gov/pubmed/32532083 http://dx.doi.org/10.3390/v12060627 |
Ejemplares similares
-
External Quality Assessment for Next-Generation Sequencing-Based HIV Drug Resistance Testing: Unique Requirements and Challenges
por: Lee, Emma R., et al.
Publicado: (2020) -
Application of a Sanger-Based External Quality Assurance Strategy for the Transition of HIV-1 Drug Resistance Assays to Next Generation Sequencing
por: Jennings, Cheryl, et al.
Publicado: (2020) -
External Quality Assessment Program for Next-Generation Sequencing-Based HIV Drug Resistance Testing: Logistical Considerations
por: Ji, Hezhao, et al.
Publicado: (2020) -
Performance comparison of next generation sequencing analysis pipelines for HIV-1 drug resistance testing
por: Lee, Emma R., et al.
Publicado: (2020) -
Dry Panels Supporting External Quality Assessment Programs for Next Generation Sequencing-Based HIV Drug Resistance Testing
por: Noguera-Julian, Marc, et al.
Publicado: (2020)